Role of Supermicrosurgical LVA for Lower Limb Lymphedema

Completed

• Conditions: Lymphedema

• Registration Number: NCT04698707
• Lead Sponsor: Chang Gung Memorial Hospital

Brief Summary

Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-28
• Primary Completion: 2020-10-05
• Study Completion: 2020-11-19
• Status Verified: 2021-01
• Study First Submitted: 2021-01-05
• Study First Submitted QC: 2021-01-05
• Last Update Submitted: 2021-01-05
• Study First Posted: 2021-01-07
• Last Update Posted: 2021-01-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 131

Inclusion Criteria

• From November 2014 to January 2019
• Lower limb lymphedema patients

Exclusion Criteria

• Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Magnetic resonance volumetry	6 months after LVA	Magnetic resonance volumetry was used for measuring preoperative and postoperative volume changes at least 6-month after LVA.

Trial Locations

Locations (1)

Kaohsiung Chang Gung Memorial Hospital; 🇨🇳 Kaohsiung, Taiwan